Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Neoplasia (New York, N.Y.)|June 8, 2006
ADAM15 disintegrin is associated with aggressive prostate and breast cancer diseaseRainer Kuefer, Kathleen C Day, Celina G Kleer, et al.
Neoplasia (New York, N.Y.)|January 16, 2007
Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancerPamela L Paris, Matthias D Hofer, Giancarlo Albo, et al.
Frontiers in Medicine|October 17, 2017
Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade GroupsAnne Offermann, Silke Hohensteiner, Christiane Kuempers, et al.
Cancer Research|March 19, 2009
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancerDavid S Rickman, Dorothee Pflueger, Benjamin Moss, et al.
International Journal of Cancer|July 5, 2019
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancerFinn Becker, Vincent Joerg, Marie C Hupe, et al.
Cancer Research|April 16, 2009
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapyMara P Steinkamp, Orla A O'Mahony, Michele Brogley, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer diseaseKilian M Gust, Matthias D Hofer, Sven R Perner, et al.
Urology|December 19, 2009
ERG rearrangement metastasis patterns in locally advanced prostate cancerSven Perner, Maria A Svensson, Ruhella R Hossain, et al.
Histopathology|June 29, 2011
Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancerMartin Braun, Veit J Scheble, Roopika Menon, et al.
Pageof 6